Public SEC Form D records
Biotech Seed Form D filings - June 2026
This page lists the 17 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Seed stage in June 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 17
- Issuers
- 16
- Combined disclosed
- $20.2M
Directory links
Filing records
17 crawlable filing links in this facet.
- Proven Proteins Inc.June 29, 2026 / Reg D 506(b) / IN$1.0M
- Chickadee Biomedicines, Inc.June 25, 2026 / Reg D 506(b) / MA$1.0M
- Boston Interactome, Inc.June 24, 2026 / Reg D 506(b) / MA$1.5M
- Petragen, Inc.June 23, 2026 / Reg D 506(b) / FL$1.0M
- Primary Bioscience, Inc.June 23, 2026 / Reg D 506(b) / WA$1.8M
- Spearhead Bio, Inc.June 23, 2026 / Reg D 506(b) / MO$1.8M
- Paralos Bioscience Inc.June 23, 2026 / Reg D 506(b) / CA$1.0M
- HAWKHILL THERAPEUTICS LtdJune 23, 2026 / Reg D 506(b)$192.6K
- Balsam Pharmaceuticals CoJune 22, 2026 / Reg D 506(b) / VA$1.0M
- Liminatus Pharma, Inc.June 18, 2026 / Reg D 506(b) / CA$1.9M
- Dendrion Epitel 1, LLCJune 15, 2026 / Reg D 506(b) / IL$1.3M
- Conexeu Sciences Inc.June 12, 2026 / Reg D 506(b) / NV$2.2K
- Duke Street Bio LtdJune 11, 2026 / Reg D 506(b)$4.1M
- Conexeu Sciences Inc.June 10, 2026 / Reg D 506(b) / NV$137.4K
- Thiogenesis Therapeutics, Corp.June 9, 2026 / Reg D 506(b)$29.0K
- Optimeos Life Sciences, Inc.June 3, 2026 / Reg D 506(b) / NJ$2.0M
- Matthias Therapeutics, LLCJune 1, 2026 / Reg D 506(b) / NJ$500.0K